Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
May
18
2021
Biden Administration Throws Down Its First Gauntlet on 340B Mintz
May
18
2021
Lawsuit Alleges Kashi Strawberry Bars Misleadingly Labeled Keller and Heckman LLP
May
18
2021
The EU and the Definition of “Nanomaterial” Keller and Heckman LLP
May
17
2021
The Empire State Legalizes Recreational Marijuana Foley & Lardner LLP
May
17
2021
European Commission and National Authorities Take a Stand Against Excessive Pricing by the Pharmaceutical Industry McDermott Will & Emery
May
17
2021
FDA Report on Salmonella Outbreak Linked to Onions Keller and Heckman LLP
May
14
2021
Update on Medical Marijuana in Mississippi: COURT VOIDS INITIATIVE 65 Bradley Arant Boult Cummings LLP
May
14
2021
Transatlantic Trade | US and Europe – Week of May 10, 2021 Squire Patton Boggs (US) LLP
May
14
2021
Pasta Slack-Fill Case against Barilla Dismissed Keller and Heckman LLP
May
14
2021
Australia Releases National Plastics Plan Keller and Heckman LLP
May
14
2021
New Definition for “Postbiotics” Keller and Heckman LLP
May
14
2021
Will There Be a Craft Marijuana Industry in New Jersey? Norris McLaughlin P.A.
May
14
2021
Introduction of a Patent Box K&L Gates
May
13
2021
Restaurant Revitalization Fund: Economic Relief for Restaurants Norris McLaughlin P.A.
May
13
2021
Virginia Enacts Employment Protections For Medical Use of Cannabis Oil Hunton Andrews Kurth
May
13
2021
International Coalition of Competition Enforcement Agencies Seek Public Comment to Explore “New or Refreshed” Theories of Competitive Harm Related to Pharmaceutical Mergers Mintz
May
13
2021
Thailand Notified WTO of Four Draft Food-Contact Regulations Keller and Heckman LLP
May
12
2021
Health Law Diagnosed — Hot Topics in FDA Regulation and Enforcement [PODCAST] Mintz
May
12
2021
CFIUS Clearance: Just Eat Takeaway.com and Grubhub Squire Patton Boggs (US) LLP
May
12
2021
Texas House Passes Plant-, Cell-, and Insect-Based Food Labeling Restrictions Keller and Heckman LLP
May
11
2021
FDA Opens Industry Portal for FSVP Records Submission Keller and Heckman LLP
May
11
2021
Massachusetts Public Health Council Approves Amendments to Clinic Licensure Regulations Mintz
May
11
2021
The U.S. Government Says “Open Sesame”: How Science Informs the Regulatory Process Womble Bond Dickinson (US) LLP
May
11
2021
Brexit and novel food procedures Keller and Heckman LLP
May
10
2021
Waiver Of Intellectual Property Protections For COVID-19 Vaccine Unlikely To Have Meaningful Impact In Short Term Sheppard, Mullin, Richter & Hampton LLP
May
10
2021
The American Families Plan & A Call for Drug Pricing Legislation Mintz
May
10
2021
FDA Notice Concerning “Healthy” Symbol Keller and Heckman LLP
May
10
2021
CNIL Issues Provisional Recommendations for Remote Quality Control of Clinical Trials During the Health Crisis McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins